ArticleNoro psikiyatri arsivi2026
Psychometric Properties of the Turkish Version of the Screen for Cognitive Impairment in Psychiatry (SCIP-TR).
Article in Noro psikiyatri arsivi, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Given the critical significance of cognitive functions in daily life and social interactions, the Screen for Cognitive Impairment in Psychiatry (SCIP) scale is particularly important in clinical practice. It can be administered quickly and offers alternative forms, avoiding issues with lengthy administration or a lack of parallel forms. This study examined the psychometric properties of the Turkish version of the SCIP scale (SCIP-TR), which enables rapid and practical assessment of cognitive impairment in psychiatric settings. Methods: This study involved 137 healthy students and hospital staff aged 18-45. Three alternative forms of the SCIP scale were adapted into Turkish using direct and reverse translation methods, and experts approved them to ensure content validity. Participants were administered one of the three alternative forms of the SCIP-TR and the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS), the Standardized Mini-Mental State Examination (SMMSE), and the Cognitive Failures Questionnaire (CFQ) scales. Test-retest reliability was evaluated using different forms of the SCIP-TR at 2-7 day intervals. The feasibility, reliability, and validity of the SCIP-TR forms were examined. Results: The analysis showed no significant differences between the three forms in total scores. Cronbach's alpha (0.715-0.750) and omega coefficients (0.709-0.784) demonstrated that the scale had acceptable internal consistency. Correlation coefficients confirmed the scale's test-retest reliability. The exploratory factor analysis unveiled a single-factor structure that accounted for 50.2% of the total variance. The moderate correlation of SCIP-TR with B-CATS, which measures similar cognitive domains, supports convergent validity. Conclusions: Findings demonstrate the validity and reliability of the Turkish version of the SCIP as a simple and practical tool for screening cognitive impairment in the general population. Its simplicity, brevity, and lack of need for a technological platform make it suitable for integration into clinical practice. Further research on SCIP-TR is needed in a more diverse demographic, including those with mental health disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.